Advertisement

Topics

De novo design of artificial IL-2 mimic for the treatment of cancer [PreClinical]

12:00 EST 7 Feb 2019 | 2 Minute Medicine

1. IL-2 is a central cytokine that enhances the immune response, with considerable potential for the treatment of cancer. 2. A mimic of IL-2 binds its receptor more tightly and more potently than the natural cytokine, without adverse effects, in mouse models of melanoma and colon cancer. Evidence Rating Level: 2 [Good] Study Rundown: As […]
Source: 2 Minute Medicine

Original Article: De novo design of artificial IL-2 mimic for the treatment of cancer [PreClinical]

NEXT ARTICLE

More From BioPortfolio on "De novo design of artificial IL-2 mimic for the treatment of cancer [PreClinical]"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cytokine
Cytokines include chemokines, lymphokines, and monokines. Cells of the immune system communicate with one another by releasing and responding to chemical messengers called cytokines. These proteins are secreted by immune cells and act on other cells to...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...